FDA Adverse Event Injury Summary report: N

MECTACER BIOLOX DELTA CERAMIC BALL HEAD 12/14 Ø 32 SIZE L +4

MDR report key: 18198433 · Received November 23, 2023

Report

Report Number
3005180920-2023-00921
Event Type
Injury
Date Received
November 23, 2023
Date of Event
October 27, 2023
Report Date
November 23, 2023
Manufacturer
MEDACTA INTERNATIONAL SA
Product Code
LZO
UDI-DI
07630030809170
PMA / PMN Number
K112115
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

BATCH REVIEW PERFORMED ON 08 NOVEMBER 2023: LOT 21C0007: 28 ITEMS MANUFACTURED AND RELEASED ON 15-JUNE-2021. EXPIRATION DATE: 2026-05-30. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, 19 ITEMS OF THE SAME LOT HAVE BEEN SOLD WITHOUT ANY SIMILAR REPORTED EVENT DURING THE PERIOD OF REVIEW. ADDITIONAL DEVICE INVOLVED BATCH REVIEW PERFORMED ON 08 NOVEMBER 2023: LINER: IMPACT 01.32.3241HC10A FACE-CHANGING 10° PE HC LINER Ø32/D (K183582) LOT 1911122: 20 ITEMS MANUFACTURED AND RELEASED ON 11-FEB-2020. EXPIRATION DATE: 2025-01-25. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, 10 ITEMS OF THE SAME LOT HAVE BEEN SOLD WITHOUT ANY SIMILAR REPORTED EVENT DURING THE PERIOD OF REVIEW.

Description of Event or Problem · 0

THE PATIENT HAD A PRIMARY HIP SURGERY ON 23 MARCH 2023. ON (B)(6) 2023, THE PATIENT CAME IN REPORTING PAIN DUE TO A DISLOCATION OF THE HEAD FROM THE LINER AND THE CAUSE OF THE DISLOCATION IS UNKNOWN. THE SURGEON REVISED LINER AND HEAD. THE SURGERY WAS COMPLETED SUCCESSFULLY. PRESENTLY, ON (B)(6) 2023, THE PATIENT CAME IN REPORTING PAIN DUE TO A DISLOCATION OF THE HEAD FROM THE LINER AND THE CAUSE OF THE DISLOCATION IS UNKNOWN. THE SURGEON REVISED THE CUP, HEAD AND LINER. THE SURGERY WAS COMPLETED SUCCESSFULLY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1240745 MECTACER BIOLOX DELTA CERAMIC BALL HEAD 12/14 Ø 32 SIZE L +4 CERAMIC BALL HEAD LZO MEDACTA INTERNATIONAL SA 21C0007 07630030809170

Patients

Seq Age Sex Outcome Treatment
1 Female Required Intervention